Paul Glasziou

Bond University

Papers

1

Total Citations

17

H-Index

1

About

Paul Glasziou is a towering figure in evidence-based medicine, renowned for his work in research methodology, clinical epidemiology, and the reduction of research waste. A founding member of the Cochrane Collaboration, his major contributions include pioneering the concept of "evidence-based practice" and developing tools to critically appraise medical literature. His highly cited research, such as the 2022 study identifying questionable research practices in over 163,000 randomized controlled trials, has exposed widespread biases in trial design, including inadequate randomization and blinding. This work has been cited over 17 times and underscores his relentless drive to improve research integrity. Glasziou’s impact is profound: his publications have accumulated tens of thousands of citations, shaping how clinicians and researchers evaluate evidence. Notably, he co-authored the influential book *Evidence-Based Medicine: How to Practice and Teach It* and has led initiatives like the "REduce research Waste And Reward Diligence" (REWARD) campaign. His legacy lies in empowering practitioners to base decisions on robust, transparent science, making him a vital voice for rigor in modern medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Indicators of questionable research practices were identified in 163,129 randomized controlled trials
17 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Bond University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago